Curcumol inhibits breast cancer growth <i>via</i> NCL/ERα36 and the PI3K/AKT pathway-Reference-Cited by-同舟云学术

Curcumol inhibits breast cancer growth via NCL/ERα36 and the PI3K/AKT pathway

Published:2023 Issue:2 Volume:14 Page:874-885
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Wei Zhou Lu¹²,Juan Wang¹³⁴⁵²,Tong Dou¹⁶,Juan Li Xiao¹,Sa Liu Yi¹,Jie Huang Fu Meng¹,Xiao Guan¹,Xiang Liu Guo¹,Jie Han Meng¹,Xu Chen¹^ORCID

Affiliation:

1. Department of Pharmacy, Guilin Medical University, Guilin 541199, P. R. China

2. Faculty of Basic Medicine, Guilin Medical University, No. 109, Guilin 541004, P. R. China

3. Key Laboratory of Pharmacognosy, Education Department of Guangxi Zhuang Autonomous Region, 541199, P. R. China

4. Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Guilin Medical University, 541001, P. R. China

5. Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, the Affiliated Hospital of Guilin Medical University, Guilin, 541001, Guangxi, China

6. School of Pharmacy, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China

Abstract

Schematic representation of the action mechanisms of curcumol.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2023/FO/D2FO02387C

Reference27 articles.

1. Antiestrogens: structure-activity relationships and use in breast cancer treatment

2. Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers

3. Management of ER positive metastatic breast cancer

4. Triple-negative breast cancer molecular subtyping and treatment progress

5. Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in small interfering RNA based therapeutic approach on breast cancer;European Journal of Pharmacology;2024-10

2. Curcumin nanopreparations: recent advance in preparation and application;Biomedical Materials;2024-08-27

3. A Theoretical Study of the Interaction of PARP-1 with Natural and Synthetic Inhibitors: Advances in the Therapy of Triple-Negative Breast Cancer;Current Issues in Molecular Biology;2024-08-27

4. Icariin‑curcumol promotes ferroptosis in prostate cancer cells through Nrf2/HO‑1 signaling;Experimental and Therapeutic Medicine;2024-03-26

5. Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure–activity relationships, and potential applications;Inflammopharmacology;2024-03-23